5592
A. K. Bhattacharya et al. / Bioorg. Med. Chem. Lett. 19 (2009) 5590–5593
Table 4
IC50 values of synthesized compounds against human cancer cell lines of different tissues
S. no.
Compound code
IC50
(lM)
Colon
CNS
Lung
Prostate
PC-3
SW-620
502713
Colo-205
SK-N-SH
A-549
1
2
3
3g
3h
3o
54.4
63.2
49.1
45.4
50
41.3
41.9
—
37.9
44.3
55
44
74.3
—
127.9
61.1
82
63.9
was heated at 100 °C, and the corresponding benzoxanthene 3a was
obtained in 95% yield (Table 2, entry 1). This success then encour-
aged us to generalize the scope of this method.13 Several structurally
diverse aldehydes (Table 2) were subjected to condensation with
b-naphthol under the catalytic influence of TaCl5 (10 mol %) and sol-
vent-free conventional heating, and 14-aryl-14H-dibenzo[a.j]-
xanthenes were obtained in high yields. Also, tolerance of the pres-
ent method towards various functionalitiespresent in the substrates
viz. ethers, methylenedioxy, halides, hydroxy and nitro groups gen-
eralizes the scope of the present method. Further, the versatility and
the utility of the present method could easily be gauged by compar-
ison with the earlier reported protocols (Table 3). We have chosen
some model substrates and the comparison has been made with re-
spect to the catalytic amount used, reaction time and yields. It is
noteworthy to mention here that 3-methoxybenzaldehyde, 4-
methoxybenzaldehyde, 4-fluorobenzaldehyde and 3-nitrobenzal-
dehyde provided the desired product within 1 h with higher yield
than the earlier reported methods.
Supplementary data
Selected NMR spectra (1H NMR, 13C NMR and DEPT spectra of
compounds 3b, 3f, 3l and 3n). Supplementary data associated with
this article can be found, in the online version, at doi:10.1016/
References and notes
1. Lambert, R. W.; Martin, J. A.; Merrett, J. H.; Parkes, K. E. B.; Thomas, G. J. PCT Int.
Appl. WO9706178, 1997; Chem. Abstr. 1997, 126, p212377y.
2. Hideo, T. Jpn. Tokkyo Koho JP56005480, 1981; Chem. Abstr. 1981, 95, 80922b.
3. Poupelin, J. P.; Saint-Ruf, G.; Foussard-Blanpin, O.; Narcisse, G.; Uehida-Ernouf,
G.; Lacroix, R. Eur. J. Med. Chem. 1978, 13, 67.
4. (a) Ion, R. M. Prog. Catal. 1997, 2, 55; (b) Ion, R. M.; Frackowiak, D.; Planner, A.;
Wiktorowicz, K. Acta Biochim. Pol. 1998, 45, 833.
5. (a) Saint-Ruf, G.; De, A.; Hieu, H. T. Bull. Chim. Ther. 1972, 7, 83; (b) Saint-Ruf, G.;
Hieu, H. T.; Poupelin, J. P. Naturwissenschaften 1975, 62, 584.
6. (a) Menchen, S. M.; Benson, S. C.; Lam, J. Y. L.; Zhen, W.; Sun, D.; Rosenblum, B.
B.; Khan, S. H.; Taing, M. U.S. Patent, US 6583168, 2003; Chem. Abstr. 2003, 139,
p54287f.; (b) Banerjee, A.; Mukherjee, A. K. Stain Technol. 1981, 56, 83; (c)
Reynolds, G. A.; Tuccio, S. A.; Peterson, O. G.; Specht, D. P. Ger. Offen. DE
2109040, 1971; Chem. Abstr. 1971, 71, p81334c.
7. (a) Sirkecioglu, O.; Talinli, N.; Akar, A. J. Chem. Res. Synop. 1995, 502; Ahmad,
M.; King, T. A.; Ko, D.-K.; Cha, B. H.; Lee, J. J. Phys. D: Appl. Phys. 2002, 35, 1473.
8. Knight, C. G.; Stephens, T. Biochem. J. 1989, 258, 683.
9. (a) Knight, D. W.; Little, P. B. Synlett 1998, 1141; (b) Knight, D. W.; Little, P. B. J.
Chem. Soc., Perkin Trans. 1 2001, 1771; (c) Bekaert, A.; Andrieux, J.; Plat, M.
Tetrahedron Lett. 1992, 33, 2805; (d) Jha, A.; Beal, J. Tetrahedron Lett. 2004, 45,
8999; (e) Kuo, C.-W.; Fang, J.-M. Synth. Commun. 2001, 31, 877; (f) Papini, P.;
Cimmarusti, R. Gazz. Chim. Ital. 1947, 77, 142; (g) Sen, R. N.; Sarkar, N. J. Am.
Chem. Soc. 1925, 47, 1079; (h) Ota, K.; Kito, T. Bull. Chem. Soc. Jpn. 1976, 49,
1167.
10. (a) Patil, S. B.; Bhat, R. P.; Samant, S. D. Synth. Commun. 2006, 36, 2163; (b)
Kumar, P. S.; Kumar, B. S.; Rajitha, B.; Reddy, P. N.; Sreenivasalu, N.; Reddy, Y. T.
Arkivoc 2006, 46; (c) Das, B.; Ravikanth, B.; Ramu, R.; Laxminarayana, K.; Rao, B.
V. J. Mol. Catal. A: Chem. 2006, 255, 74; (d) Khosropour, A. R.; Khodaei, M. M.;
Moghannian, H. Synlett 2005, 955; (e) Rajitha, B.; Kumar, B. S.; Reddy, Y. T.;
Reddy, P. N.; Sreenivasulu, N. Tetrahedron Lett. 2005, 46, 8691; (f) Bhattacharya,
A. K.; Rana, K. C. Mendeleev Commun. 2007, 17, 247; (g) Saini, A.; Kumar, S.;
Sandhu, J. S. Synlett 2006, 1928; (h) Sarma, R. J.; Baruah, J. B. Dyes. Pigm. 2005,
64, 91.
All the compounds were assayed for in vitro cytotoxicity14
against a panel of six human cancer cell lines including SW-620,
502713 and Colo-205 (Colon), SKNSH (CNS), A-549 (Lung) and
PC-3 (Prostate) using sulforhodamine B. The synthesized 14-aryl-
14H-dibenzo[a.j]xanthenes were evaluated against six cancer lines
for their cytotoxic profiles and the results are summarized in Table
4. Compound 3g having 4-hydr-oxy-3-methoxy aryl showed sig-
nificant cytotoxic activity against Colo-205 with an IC50 value of
41.9 lM whereas other similarly substituted compounds in this
series (3b, 3d, 3e and 3f) were devoid of any cytotoxic activity.
O-Nitro substituted aryl (3h) showed some degree of cytotoxic
activity against different colon, CNS and prostrate cell lines
whereas p- or m-nitro substituted aryls (3i and 3j, respectively)
did not show cytotoxic activity against any human cancer cell
lines. The more polar compound having two aliphatic hydroxyl
groups (3o) showed more potent cytotoxic activity against Colo-
205 and Colon-502713 with an IC50 value of 37.9 and 41.3
respectively.
lM,
11. (a) Bhattacharya, A. K.; Kaur, T. Synlett 2007, 745; (b) Bhattacharya, A. K.;
Mujahid, M.; Natu, A. A. Synth. Commun. 2008, 38, 128; (c) Bhattacharya, A. K.;
Diallo, M. A.; Ganesh, K. N. Synth. Commun. 2008, 38, 1518; (d) Bhattacharya, A.
K.; Rana, K. C. Tetrahedron Lett. 2008, 49, 2598.
In conclusion, a novel and highly efficient procedure has been
developed for the synthesis of 14-aryl-14H-dibenzo[a.j]xanthenes
by condensation reaction of diverse aldehydes with b-naphthol in
one-pot using TaCl5 as the catalyst under solvent-free condition.
The main advantages of the present method are: solvent-free reac-
tion conditions, good to excellent yields, simple work-up and puri-
fication of the products. Also, some of the synthesized compounds
(3g, 3h and 3o) have shown cytotoxic activities in micro molar
range thereby suggesting that these moieties could be further
developed as possible anticancer agents by the structural
modifications.
12. (a) Kirihara, M.; Harano, A.; Tsukiji, H.; Takizawa, R.; Uchiyama, T.; Hatano, A.
Tetrahedron Lett. 2005, 46, 6377; (b) Chandrasekhar, S.; Takhi, M.; Reddy, Y. R.;
Mohapatra, S.; Rama Rao, C.; Reddy, K. V. Tetrahedron 1997, 53, 14997; (c)
Chandrasekhar, S.; Takhi, M.; Uma, G. Tetrahedron Lett. 1997, 38, 8089; (d)
Chandrasekhar, S.; Ramachandar, T.; Takhi, M. Tetrahedron Lett. 1998, 39, 3263;
(e) Chandrasekhar, S.; Ramachandar, T.; Jaya Prakash, S. Synthesis 2000, 1817.
13. General Synthetic procedure: to a mixture of aldehyde (1 mmol), and b-naphthol
(2 mmol), TaCl5 (10 mol %) was added and heated at 100 °C for the appropriate
time (Table 1) till the completion (TLC) of reaction. The reaction mass was
cooled to room temperature, DCM (25 mL) was added to it and washed with
water. The DCM extract was dried (anhydrous Na2SO4), filtered and evaporated
to furnish a solid residue. The pure 14-aryl-14H-dibenzo[a.j]xanthene was
obtained by recrystallization of the solid from EtOH. All the products were
characterized by spectral data.15
Acknowledgments
14. In vitro cytotoxicity of synthesized compounds against human cancer cell lines: the
human cancer cell lines were procured from National Cancer Institute,
Frederick, USA. Cells were grown in tissue culture flasks in complete growth
medium (RPMI-1640 medium with 2 mM glutamine, pH 7.4, supplemented
A.K.B. is grateful to Dr. S. Sivaram, Director, NCL, Pune and Dr.
Ganesh Pandey, Head, Division of Organic Chemistry for their con-
stant encouragement and support. K.C.R. is grateful to the Council
of Scientific and Industrial Research (CSIR), New Delhi for a Senior
Research Fellowship.
with 10% fetal calf serum, 100 lg/ml streptomycin and 100 units/ml penicillin)
in a carbon dioxide incubator (37 °C, 5% CO2, 90% RH). The cells at subconfluent
stage were harvested from the flask by treatment with trypsin [0.05% in PBS
(pH 7.4) containing 0.02% EDTA]. Cells with viability of more than 98% as
determined by trypan blue exclusion were used for determination of